Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury
Authors:
- 15 May 2023
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 17 (6) , 1626-1636
Abstract
Background and aims Some drug-induced liver injury (DILI) cases may become chronic, even after drug withdrawal. Radiomics can predict liver disease progression. We established and validated a predictive model incorporating the clinical characteristics and radiomics features for predicting chronic DILI. Methods One hundred sixty-eight DILI patients who underwent liver gadolinium-diethylenetriamine pentaacetate-enhanced magnetic resonance imaging were recruited. The patients were clinically diagnosed using the Roussel Uclaf causality assessment method. Patients who progressed to chronicity or recovery were randomly divided into the training (70%) and validation (30%) cohorts, respectively. Hepatic T1-weighted images were segmented to extract 1672 radiomics features. Least absolute shrinkage and selection operator regression was used for feature selection, and Rad-score was constructed using support vector machines. Multivariable logistic regression analysis was performed to build a clinic-radiomics model incorporating clinical characteristics and Rad-scores. The clinic-radiomics model was evaluated for its discrimination, calibration, and clinical usefulness in the independent validation set. Results Of 1672 radiomics features, 28 were selected to develop the Rad-score. Cholestatic/mixed patterns and Rad-score were independent risk factors of chronic DILI. The clinic-radiomics model, including the Rad-score and injury patterns, distinguished chronic from recovered DILI patients in the training (area under the receiver operating characteristic curve [AUROC]: 0.89, 95% confidence interval [95% CI]: 0.87–0.92) and validation (AUROC: 0.88, 95% CI: 0.83–0.91) cohorts with good calibration and great clinical utility. Conclusion The clinic-radiomics model yielded sufficient accuracy for predicting chronic DILI, providing a practical and non-invasive tool for managing DILI patients.Keywords
Funding Information
- National Natural Science Foundation of China (82070604, 82270618, 82100646, 81970514, 81900527)
- Key projects of Shanghai Health Commission (202040111)
- Shanghai Municipal Key Clinical Specialty (shslczdzk01103)
- Shanghai Ruijin Hospital Three-Year Plan of the Clinical Skills and Innovations (2018CR005)
This publication has 29 references indexed in Scilit:
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective StudyGastroenterology, 2015
- Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence RiskIEEE Transactions on Biomedical Engineering, 2015
- Clinical and Histologic Features of Azithromycin-Induced Liver InjuryClinical Gastroenterology and Hepatology, 2015
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver InjuryAmerican Journal of Gastroenterology, 2014
- Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From OnsetGastroenterology, 2014
- Contrast Enhanced Liver MRI in Patients with Primary Sclerosing CholangitisAcademic Radiology, 2011
- The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryHepatology, 2011
- The long-term follow-up after idiosyncratic drug-induced liver injury with jaundiceJournal of Hepatology, 2009
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990